(Q35112005)

6 August 2017

title

Inhibition of duck hepatitis B virus DNA replication by antiviral chemotherapy with ganciclovir-nalidixic acid (English)

1 reference

6 August 2017

1 reference

1 reference

1 reference

Wang Y

1

1 reference

6 August 2017

Luscombe C

2

1 reference

6 August 2017

Bowden S

3

1 reference

6 August 2017

Shaw T

4

1 reference

6 August 2017

Locarnini S

5

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 February 1995

1 reference

6 August 2017

number of pages

3

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

6 August 2017

volume

39

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

556-558

1 reference

In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162580

The half-life of duck hepatitis B virus supercoiled DNA in congenitally infected primary hepatocyte cultures

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162580

Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: analysis of intrahepatic replicative hepatitis B virus DNA.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162580

Effects of adenine arabinoside on serum and intrahepatic replicative forms of duck hepatitis B virus in chronic infection

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162580

Virus-liver cell interactions in duck hepatitis B virus infection. A study of virus dissemination within the liver

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162580

Foscarnet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162580

Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162580

In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162580

Ganciclovir--a review of pharmacology, therapeutic efficacy and potential use for treatment of congenital cytomegalovirus infections

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162580

DNA topoisomerases as potential targets of antiviral action

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162580

Inhibition of duck hepatitis B virus replication by 2',3'-dideoxycytidine. A potent inhibitor of reverse transcriptase

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162580

Appearance of viral RNA transcripts in the early stage of duck hepatitis B virus infection

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162580

Approaches to the treatment of hepatitis B virus and delta-related liver disease

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162580

In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162580

Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162580

Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162580

Alterations in intrahepatic expression of duck hepatitis B viral markers with ganciclovir chemotherapy

27 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7726533

12 December 2020

inferred from PubMed ID database lookup

Inhibition of HBV DNA replication by ganciclovir in patients with AIDS

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7726533

12 December 2020

inferred from PubMed ID database lookup

Long-term remission of chronic hepatitis B after alpha-interferon therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7726533

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.39.2.556

1 reference

6 August 2017

1 reference

6 August 2017

1 reference